NCT02199418View on ClinicalTrials.gov

Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

November 30, 2015

Study Completion Date

October 31, 2016

Conditions
Tubular Breast CancerMucinous Breast CancerInvasive Ductal Breast CancerInflammatory Breast Cancer
Interventions
DRUG

Paclitaxel

DRUG

Cisplatin

Trial Locations (2)

200032

Fudan University Shanghai Cancer Center, Shanghai

200127

Shanghai Jiaotong University School of Medicine, Renji Hospital, Shanghai

All Listed Sponsors
lead

RenJi Hospital

OTHER

NCT02199418 - Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast Cancer | Biotech Hunter | Biotech Hunter